ES2284028T5 - Nueva composición de galactooligosacárido y la preparación de la misma - Google Patents

Nueva composición de galactooligosacárido y la preparación de la misma Download PDF

Info

Publication number
ES2284028T5
ES2284028T5 ES04743163.0T ES04743163T ES2284028T5 ES 2284028 T5 ES2284028 T5 ES 2284028T5 ES 04743163 T ES04743163 T ES 04743163T ES 2284028 T5 ES2284028 T5 ES 2284028T5
Authority
ES
Spain
Prior art keywords
gal
milk
glc
lactose
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES04743163.0T
Other languages
English (en)
Spanish (es)
Other versions
ES2284028T3 (es
Inventor
Anthony Graham Wynne
Glenn Gibson
Jacek Witold Slupinski
Georgios Tzortzis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Clasado Inc
Original Assignee
Clasado Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33568264&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2284028(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GB0315266A external-priority patent/GB0315266D0/en
Priority claimed from GB0325224A external-priority patent/GB0325224D0/en
Priority claimed from GB0405837A external-priority patent/GB0405837D0/en
Application filed by Clasado Inc filed Critical Clasado Inc
Application granted granted Critical
Publication of ES2284028T3 publication Critical patent/ES2284028T3/es
Publication of ES2284028T5 publication Critical patent/ES2284028T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nutrition Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Feed For Specific Animals (AREA)
ES04743163.0T 2003-06-30 2004-06-30 Nueva composición de galactooligosacárido y la preparación de la misma Expired - Lifetime ES2284028T5 (es)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GB0315266A GB0315266D0 (en) 2003-06-30 2003-06-30 Novel galactooligosaccharide composition and the preparation thereof
GB0315266 2003-06-30
GB0325224A GB0325224D0 (en) 2003-10-29 2003-10-29 Novel galactooligosaccharide composition and the preparation thereof
GB0325224 2003-10-29
GB0405837 2004-03-16
GB0405837A GB0405837D0 (en) 2004-03-16 2004-03-16 Novel Galactooligosaccharide composition and the preparation thereof
PCT/GB2004/002815 WO2005003329A1 (en) 2003-06-30 2004-06-30 Novel galactooligosaccharide composition and the preparation thereof

Publications (2)

Publication Number Publication Date
ES2284028T3 ES2284028T3 (es) 2007-11-01
ES2284028T5 true ES2284028T5 (es) 2014-12-04

Family

ID=33568264

Family Applications (1)

Application Number Title Priority Date Filing Date
ES04743163.0T Expired - Lifetime ES2284028T5 (es) 2003-06-30 2004-06-30 Nueva composición de galactooligosacárido y la preparación de la misma

Country Status (21)

Country Link
US (1) US7883874B2 (en:Method)
EP (1) EP1644482B2 (en:Method)
JP (2) JP4384656B2 (en:Method)
KR (1) KR100857500B1 (en:Method)
AT (1) ATE360682T1 (en:Method)
AU (1) AU2004254110B2 (en:Method)
BR (1) BRPI0408911B1 (en:Method)
CA (1) CA2520043C (en:Method)
CY (1) CY1107671T1 (en:Method)
DE (1) DE602004006133T3 (en:Method)
DK (1) DK1644482T4 (en:Method)
ES (1) ES2284028T5 (en:Method)
GB (1) GB2412380B (en:Method)
IL (1) IL172553A (en:Method)
MX (1) MXPA05010349A (en:Method)
NO (1) NO335413B1 (en:Method)
NZ (1) NZ542482A (en:Method)
PL (1) PL1644482T5 (en:Method)
PT (1) PT1644482E (en:Method)
RU (1) RU2313572C2 (en:Method)
WO (1) WO2005003329A1 (en:Method)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA05010349A (es) * 2003-06-30 2006-03-08 Clasado Inc Composicion novedosa de galactooligosacaridos y preparacion de la misma.
WO2006012536A2 (en) 2004-07-22 2006-02-02 Ritter Andrew J Methods and compositions for treating lactose intolerance
WO2019090180A1 (en) 2017-11-03 2019-05-09 Kaleido Biosciences, Inc. Glycan preparations for the treatment of infection
GB0522740D0 (en) * 2005-11-08 2005-12-14 Clasado Inc Process for the production of oligosaccharides
GB0525857D0 (en) * 2005-12-20 2006-02-01 Product and process
EP1803358A1 (en) 2005-12-28 2007-07-04 Laboratorios Ordesa, S.L Infant immunological formula
GB0601901D0 (en) 2006-01-31 2006-03-08 Product and Process
ATE468027T1 (de) † 2006-02-10 2010-06-15 Nestec Sa Oligosaccharidmischung
GB0606112D0 (en) * 2006-03-28 2006-05-03 Product and process
FR2900029B1 (fr) * 2006-04-25 2012-09-14 Bel Fromageries Procede d'aromatisation de produits fromagers.
EP1887017A1 (en) * 2006-08-09 2008-02-13 Friesland Brands B.V. Prebiotic carbohydrate
SI2076271T1 (sl) 2006-10-02 2011-12-30 Friesland Brands Bv Inhibicija toksinov kolere z galatooligosaharidi (GOS)
EP1988096A1 (en) * 2007-04-26 2008-11-05 Laboratorios Ordesa, S.L Process for preparing a galactooligosaccharides powder
WO2009113030A2 (en) * 2008-03-12 2009-09-17 Tata Chemicals Ltd. Process for the production of galactooligosaccharides by free cells
GB0809921D0 (en) * 2008-05-30 2008-07-09 Clasado Inc Product and process therefor
US20090297660A1 (en) * 2008-06-02 2009-12-03 Kraft Food Holdings, Inc. Cheese Products Containing Galacto-Oligosaccharides And Having Reduced Lactose Levels
KR101121161B1 (ko) 2009-02-24 2012-03-19 주식회사 제노포커스 고당전이 활성의 신규한 베타-갈락토시다제 및 그 용도
US8785160B2 (en) 2009-02-24 2014-07-22 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
KR20170053733A (ko) 2009-02-24 2017-05-16 리터 파마슈티컬즈 인코오포레이티드 프리바이오틱 제제 및 사용 방법
JP2012520325A (ja) * 2009-03-13 2012-09-06 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア プレバイオティックオリゴ糖
GB0906983D0 (en) * 2009-04-23 2009-06-03 Clasado Inc Novel use
CA2763384C (en) * 2009-05-27 2014-07-08 Clasado Inc Use of a composition of a mixture of galactooligosaccharides for preventing diarrhoea
TWI446914B (zh) * 2009-06-04 2014-08-01 Clasado Inc 製備預防旅人腹瀉發生藥物之組成物之用途
WO2010143940A1 (en) * 2009-06-12 2010-12-16 N.V. Nutricia Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
IT1395068B1 (it) * 2009-08-07 2012-09-05 Inalco Spa Processo per la produzione di galatto-oligosaccaridi ultrapuri
US20110189342A1 (en) * 2010-02-01 2011-08-04 Jeong Hea-Seok High-purity galactooligosaccharides and uses thereof
IL206678A0 (en) 2010-06-28 2010-12-30 Hcl Cleantech Ltd A method for the production of fermentable sugars
EA201300150A1 (ru) * 2010-07-19 2013-08-30 Арла Фудс Амба Способ изготовления продукта, содержащего галактоолигосахарид, и полученный на основе способа продукт
JP2017018135A (ja) * 2010-07-19 2017-01-26 アルラ フーズ アムバＡｒｌａ Ｆｏｏｄｓ Ａｍｂａ ガラクトオリゴ糖含有組成物およびそれを生産する方法
ES2610908T3 (es) * 2011-01-31 2017-05-04 Synformulas Gmbh Cepas de bifidobacterium bifidum para su aplicación en enfermedades gastrointestinales
GB2492559B (en) 2011-07-05 2018-07-25 Clasado Inc Composition and method for preventing or reducing the risk of developing a syndrome
CN107595860A (zh) 2011-07-22 2018-01-19 雅培制药有限公司 用于预防胃肠道损伤和/或促进胃肠道修复的低聚半乳糖
WO2013035737A1 (ja) * 2011-09-08 2013-03-14 株式会社ヤクルト本社 新規ビフィズス菌及びその利用
WO2013055785A1 (en) 2011-10-10 2013-04-18 Virdia Ltd Sugar compositions
CN103889238B (zh) * 2011-10-18 2017-10-13 雀巢产品技术援助有限公司 用于脑生长和/或认知和/或心理运动发育的组合物
US20150087616A1 (en) * 2011-11-30 2015-03-26 Ritter Pharmaceuticals, Inc. Prebiotic formulations and methods of use
US8894771B2 (en) 2011-12-30 2014-11-25 Renmatix, Inc. Compositions comprising C5 and C6 monosaccharides
EP2814454A2 (en) 2012-02-14 2014-12-24 The Procter and Gamble Company Topical use of a skin-commensal prebiotic agent and compositions containing the same
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
CA2913393A1 (en) 2013-05-24 2014-11-27 General Mills, Inc. Food products with yogurt whey
EP3030093B1 (en) * 2013-07-26 2017-09-06 Novozymes A/S POLYPEPTIDES HAVING alpha-L-GALACTOSIDASE ACTIVITY AND POLYNUCLEOTIDES ENCODING SAME
US20160219916A1 (en) * 2013-08-30 2016-08-04 Abbott Laboratories Oral rehydration compositions with galactooligosaccharides
GB201319531D0 (en) * 2013-11-05 2013-12-18 Optibiotix Health Ltd Composition & methods of screening
WO2015095747A1 (en) 2013-12-20 2015-06-25 Abbott Laboratories Oral rehydration composition with oligosaccharides
ES2701163T3 (es) 2014-01-20 2019-02-21 Jennewein Biotechnologie Gmbh Procedimiento para la purificación eficiente de oligosacáridos de la leche humana (HMO) neutros a partir de la fermentación microbiana
CN111471117A (zh) 2014-07-09 2020-07-31 卡德纳生物有限公司 低聚糖组合物及其制备方法
JPWO2016080448A1 (ja) * 2014-11-19 2017-08-24 株式会社ヤクルト本社 セリアック病予防治療剤
CN112226466A (zh) 2015-01-07 2021-01-15 威尔迪亚公司 萃取和转化半纤维素糖的方法
PT3250048T (pt) 2015-01-26 2019-11-18 Cadena Bio Inc Composições de oligossacáridos para utilização como ração para animais e métodos para a sua produção
ES2857557T3 (es) 2015-01-26 2021-09-29 Kaleido Biosciences Inc Compuestos terapéuticos de glicano y métodos relacionados de los mismos
JP2018517677A (ja) 2015-04-23 2018-07-05 カレイド・バイオサイエンシズ・インコーポレイテッド グリカン治療剤及び治療方法
CA2985478A1 (en) 2015-05-27 2016-12-01 Virdia, Inc. Integrated methods for treating lignocellulosic material
US10190142B2 (en) 2016-01-25 2019-01-29 King-Prebiotics Biotechnology (Tw) Co., Ltd. High-purity galactooligosaccharide compositions, preparations, and applications thereof
WO2017219106A1 (pt) * 2016-06-24 2017-12-28 Yessinergy Holding S/A Composição imunomoduladora e promotora de crescimento e de controle da população de bactérias indesejáveis da microbiota intestinal e seu uso
EP4295840A3 (en) 2016-12-06 2024-03-13 DSM Nutritional Products, LLC Glycan polymers and related methods thereof
KR101955251B1 (ko) 2017-07-31 2019-03-08 최승오 독서대 겸용 얼굴베개
WO2019090182A2 (en) 2017-11-03 2019-05-09 Kaleido Biosciences, Inc. Glycan preparations and methods of use for hyperammonemia
US12410206B2 (en) 2018-08-21 2025-09-09 Dsm Nutritional Products, Llc Oligosaccharide compositions and methods of use thereof for reducing ammonia levels
KR20210089706A (ko) 2018-11-08 2021-07-16 칼레이도 바이오사이언시즈, 인크. 올리고사카라이드 조성물 및 그의 사용 방법
KR20210146295A (ko) * 2019-03-29 2021-12-03 가부시키가이샤 야쿠르트 혼샤 식사 유래의 다당의 이용성이 높은 신규 비피도박테리움속 세균
PH12021552677A1 (en) * 2019-05-15 2022-07-04 Nutricia Nv Beta-1,3'-galactosyllactose for the treatment of gut barrier function diseases
WO2023275391A1 (en) * 2021-07-01 2023-01-05 N.V. Nutricia Nutritonal compositions for gut barrier function
GB202200069D0 (en) * 2022-01-05 2022-02-16 Vemico Ltd Compositions and methods for immunomodulation via control of intestinal microbiome
GB2619977A (en) * 2022-06-24 2023-12-27 Clasado Res Services Limited Compositions and uses thereof
GB2623336A (en) * 2022-10-12 2024-04-17 Clasado Res Services Limited Compositions and uses thereof

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4435389A (en) 1980-07-07 1984-03-06 Kabushiki Kaisha Yakult Honsha Composition for promoting growth of bifidobacteria
JPS6259290A (ja) 1985-09-09 1987-03-14 Riyoushiyoku Kenkyukai イソラフイノ−ス及びその製造方法
JP2711095B2 (ja) 1986-09-27 1998-02-10 ユニチカ株式会社 ビフイドバクテリウム菌の増殖促進剤の製造法
DK199887D0 (da) 1987-04-15 1987-04-15 Danisco Bioteknologi As Gaerstamme
JP2518663B2 (ja) 1987-12-24 1996-07-24 株式会社ヤクルト本社 ガラクトオリゴ糖含有加工乳の製造法
FR2640997A1 (en) 1988-12-22 1990-06-29 Ajinomoto Kk Process for the manufacture of a galactose transfer product.
JP2819312B2 (ja) 1989-07-18 1998-10-30 焼津水産化学工業株式会社 Ｎ―アセチルラクトサミンの製造法
JP2819313B2 (ja) 1989-07-18 1998-10-30 焼津水産化学工業株式会社 Ｎ―アセチルラクトサミンの製造方法
CA2027835A1 (en) 1990-01-19 1991-07-20 William D. Prevatt Strains of phaffia rhodozyma containing high levels of astaxanthin
JP2750767B2 (ja) 1990-02-21 1998-05-13 雪印乳業株式会社 新規糖アルコール
JP2952439B2 (ja) 1991-11-26 1999-09-27 株式会社ホーネンコーポレーション 新規飲食品素材
JPH05146296A (ja) 1991-11-27 1993-06-15 Yakult Honsha Co Ltd β−ガラクトシダーゼ遺伝子を含むＤＮＡ断片及び該ＤＮＡ断片を組み込んだプラスミド
JP2904687B2 (ja) 1993-09-17 1999-06-14 雪印乳業株式会社 新規オリゴ糖
FR2723963B1 (fr) 1994-08-31 1997-01-17 Gervais Danone Co Preparation de produits fermentes par streptococcus thermophilus, enrichis en galacto-oligosaccharides et en beta-galactosidase
JP3246296B2 (ja) 1995-11-09 2002-01-15 宇部興産株式会社 半溶融金属の成形方法
JPH1023898A (ja) 1996-07-10 1998-01-27 Meiji Milk Prod Co Ltd Ｎ−アセチルラクトサミン誘導体の新規な製造法
KR100245383B1 (ko) 1996-09-13 2000-03-02 정훈보 교차홈 형성 전열관 및 그 제조 방법
JP2894293B2 (ja) 1996-09-17 1999-05-24 不二製油株式会社 ガラクタナーゼｓ−３９及びこれを産生するバチルスエスピーｓ−３９
NL1010770C2 (nl) * 1998-12-09 2000-06-13 Nutricia Nv Preparaat dat oligosacchariden en probiotica bevat.
JP3049693B1 (ja) 1998-12-10 2000-06-05 ソフィアインターナショナル株式会社 端末ターミナル
FR2789086B1 (fr) 1999-02-03 2003-01-31 Alain Rambach Procede de detection de bacteries cultivees en condition anaerobie
ATE352611T1 (de) * 2000-05-26 2007-02-15 Arla Foods Amba Isolierte beta-galactosidase von bifidobacterium
EP1227152A1 (en) 2001-01-30 2002-07-31 Société des Produits Nestlé S.A. Bacterial strain and genome of bifidobacterium
GB0229015D0 (en) * 2002-12-12 2003-01-15 Novartis Nutrition Ag New Compound
GB0303716D0 (en) 2003-02-18 2003-03-19 Mars Uk Ltd Food product and process
MXPA05010349A (es) * 2003-06-30 2006-03-08 Clasado Inc Composicion novedosa de galactooligosacaridos y preparacion de la misma.

Also Published As

Publication number Publication date
DK1644482T3 (da) 2007-08-13
ES2284028T3 (es) 2007-11-01
EP1644482B1 (en) 2007-04-25
JP4384656B2 (ja) 2009-12-16
CY1107671T1 (el) 2013-04-18
JP2009189374A (ja) 2009-08-27
DK1644482T4 (da) 2014-12-15
PL1644482T3 (pl) 2007-09-28
ATE360682T1 (de) 2007-05-15
CA2520043A1 (en) 2005-01-13
KR20050111624A (ko) 2005-11-25
GB2412380B (en) 2005-11-09
AU2004254110A1 (en) 2005-01-13
BRPI0408911B1 (pt) 2016-07-26
DE602004006133D1 (de) 2007-06-06
NZ542482A (en) 2008-05-30
EP1644482B2 (en) 2014-10-01
RU2005129997A (ru) 2006-06-10
GB0513376D0 (en) 2005-08-03
DE602004006133T2 (de) 2007-11-22
KR100857500B1 (ko) 2008-09-08
RU2313572C2 (ru) 2007-12-27
PT1644482E (pt) 2007-06-25
US20070274955A1 (en) 2007-11-29
PL1644482T5 (pl) 2015-05-29
IL172553A (en) 2010-06-30
NO335413B1 (no) 2014-12-08
EP1644482B8 (en) 2007-10-03
US7883874B2 (en) 2011-02-08
IL172553A0 (en) 2006-04-10
AU2004254110B2 (en) 2007-01-04
EP1644482A1 (en) 2006-04-12
JP2007527199A (ja) 2007-09-27
BRPI0408911A (pt) 2006-03-28
DE602004006133T3 (de) 2014-12-24
CA2520043C (en) 2009-09-01
WO2005003329A1 (en) 2005-01-13
HK1077323A1 (en) 2006-02-10
GB2412380A (en) 2005-09-28
JP4932874B2 (ja) 2012-05-16
MXPA05010349A (es) 2006-03-08
NO20056004L (no) 2006-01-03

Similar Documents

Publication Publication Date Title
ES2284028T5 (es) Nueva composición de galactooligosacárido y la preparación de la misma
Djouzi et al. Compared effects of three oligosaccharides on metabolism of intestinal microflora in rats inoculated with a human faecal flora
Losada et al. Towards a healthier diet for the colon: the influence of fructooligosaccharides and lactobacilli on intestinal health
CN109430666A (zh) 一种益生菌冻干粉固体饮料
RS58869B1 (sr) Kompozicije koje sadrže blautia bakterijske sojeve za lečenje visceralne hipersenzitivnosti
CN103053904A (zh) 一种具有调节肠道菌群功能的复合功能糖
CN102670662A (zh) 糖醛酸和益生菌
WO2015071401A1 (en) Compositions for use in the prevention or treatment of necrotizing enterocolitis in infants or young children born by c-section
CN104642870A (zh) 一种益生元组合物
CN120505227A (zh) 菌株和组合物
CN101372679B (zh) 一种双歧双歧杆菌菌株及其使用方法
GB2628547A (en) Probiotic and postbiotic compositions, products and uses thereof
CN112806577B (zh) 产丁酸的益生元益生菌增效组合
Marks 3 Successful Probiotic Bifidobacteria
WO2025099321A1 (en) Compositions comprising human milk oligosaccharides and inactivated cells of a microorganism